Population-wide cohort study of statin use for the secondary cardiovascular disease prevention in Scotland in 2009-2017.

Inna Thalmann David Preiss Iryna Schlackow Alastair M Gray Borislava Mihaylova

Published in: Heart (British Cardiac Society) (2022)

Statin use remains suboptimal for the secondary ASCVD prevention, particularly in women and older patients, and following ischaemic stroke and PAD hospitalisations. Improving this would offer substantial benefits to population health at low cost.

Keyphrases

cardiovascular disease
low cost
coronary artery disease
polycystic ovary syndrome
type diabetes
cardiovascular events
cardiovascular risk factors
pregnancy outcomes
metabolic syndrome
low density lipoprotein